As of 2026-04-27, the EV/EBITDA ratio of Aerie Pharmaceuticals Inc (AERI) is -58.69. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Aerie's latest enterprise value is 1,012.11 mil USD. Aerie's TTM EBITDA according to its financial statements is -17.25 mil USD. Dividing these 2 quantities gives us the above Aerie EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 14.1x - 17.2x | 16.2x |
| Forward P/E multiples | 13.2x - 15.8x | 14.9x |
| Fair Price | (10.16) - (10.74) | (10.66) |
| Upside | -166.6% - -170.4% | -169.9% |
| Date | EV/EBITDA |